Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-05 to 2024-03-06
Current total value of award: $46.68
Description: 4563859201!ARTIFICIAL TEARS SOLU